跳至主要内容
临床试验/NCT07408167
NCT07408167尚未招募不适用

Performance of AI Models in the Clinical Pathology Diagnostic Workflow: A Multicenter, Prospective, Randomized Controlled Trial

Nanfang Hospital, Southern Medical University3 个研究点 分布在 1 个国家目标入组 2,060 人开始时间: 2026年3月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
2,060
试验地点
3
主要终点
Area under ROC curve (AUC)

研究概览

简要总结

The investigators plan to conduct a multicenter, prospective, randomized controlled trial to systematically evaluate the incremental value of pathology-based artificial intelligence (AI) models in a pan-disease diagnostic workflow. The study will primarily compare interpretation using an AI-assisted platform with conventional independent slide reading in terms of diagnostic accuracy (e.g., AUC), reading efficiency (e.g., diagnostic time), diagnostic report quality, diagnostic confidence (Likert scale), and pathologists' satisfaction with the AI model. Investigators will also assess superiority among less experienced (junior) pathologists and non-inferiority among more experienced (senior) pathologists. Successful completion of this project will provide high-level prospective evidence to support standardized deployment, quality control, and broader implementation of pathology AI in clinical practice. This trial may also evaluate the potential benefits and risks of using AI tools in medical research.

详细描述

In this study, investigators plan to enroll 60 pathologists with varying levels of experience and 2,000 patients requiring pathological diagnosis, with whole-slide images (WSIs) collected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologists:
  • Inclusion Criteria:
  • Voluntarily provide written informed consent.
  • Age ≥ 20 years.
  • Have completed at least 1 year of training in pathological diagnosis.

排除标准

  • Individuals with reading difficulties or a reading disorder.
  • Unwilling to participate in this study.
  • Inclusion Criteria:
  • Voluntarily provide written informed consent.
  • Age ≥ 18 years.
  • Have available digital pathology images and relevant clinical information.
  • Exclusion Criteria:
  • Missing data or data quality not meeting the requirements for analysis.
  • Deemed unsuitable for participation by the investigator.
  • Unwilling to participate in this study.

研究组 & 干预措施

AI-assisted group

Experimental

Pathologists in this group are required to use the AI pathology diagnostic model to assist their diagnoses. The AI pathology model will provide a predicted result for each case.

干预措施: AI model (Other)

Independent Diagnosis Group (Control Group)

Placebo Comparator

In this group, pathologists will independently diagnose each case based on their own clinical experience, and will record both their time to diagnosis and their diagnostic confidence.

干预措施: Control (Other)

结局指标

主要结局

Area under ROC curve (AUC)

时间窗: Assessments will be conducted within one week after the pathologists' diagnoses

Area under the curve

次要结局

  • Diagnostic time per case(Measured immediately after the pathologists' diagnosis)
  • Pathologists' diagnostic confidence(At the time of diagnosis for each case.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验